Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus

Neurobiology of Aging

Volumn 34, Issue 10, 2013, Pages 2293-2301

  Bardou, Isabelle ^a   Brothers, Holly M ^a   Kaercher, Roxanne M ^a   Hopp, Sarah C ^a   Wenk, Gary L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aging; Cytokines; Lipopolysaccharide; Migroglia; PCR; Rats; Water pool task

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; COGNITION; CONTROLLED STUDY; DISEASE DURATION; GENE EXPRESSION; HIPPOCAMPUS; JUVENILE ANIMAL; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; WORKING MEMORY;

AGING; CYTOKINES; LIPOPOLYSACCHARIDE; MIGROGLIA; PCR; RATS; WATER POOL TASK;

AGING; ANIMALS; CEREBROSPINAL FLUID; CYTOKINES; HIPPOCAMPUS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MEMORY; MICROGLIA; NEUROGENIC INFLAMMATION; RATS; RATS, INBRED F344;

EID: 84879881111     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.03.034     Document Type: Article

References (69)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community based, prospective study. Neurology 2001, 56:730-736.
2. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., Kosugi A., Miyake K. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J.Exp. Med. 2003, 198:1035-1042.
3. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Landreth G., McGeer P.L., Mrak R., MacKenzie I., O'Banion K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray A. Inflammation in Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
4. Andersen K., Lolk A., Kragh-Sorensen P., Petersen N.E., Green A. Depression and the risk of Alzheimer disease. Epidemiology 2005, 16:233-238.
5. Bachstetter A.D., Norris C.M., Sompol P., Wilcock D.M., Goulding D., Neltner J.H., Clair D.S., Watterson D.M., Van Eldik L.J. Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology. J.Neurosci. 2012, 32:10201-10210.
6. Balakrishnan K., Verdile G., Mehta P.D., Beilby J., Nolan D., Galvao D.A., Newton R., Gandy S.E., Martins R.N. Plasma Aβ42 correlates positively with increased body fat in healthy individuals. J.Alzheimers Dis. 2005, 8:269-282.
7. Bardou I., DiPatrizio N., Brothers H.M., Kaercher R.M., Baranger K., Mitchem M., Hopp S.C., Wenk G.L., Marchalant Y. Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging. Health 2012, 4:679-684.
8. Barrientos R.M., Frank M.G., Watkins L.R., Maier S.F. Memory impairments in healthy aging: role of aging-induced microglial sensitization. Aging Dis. 2010, 1:212-231.
9. Biessels G., Kappelle L.J. Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or inslin-induced amyloid pathology?. Biochem. Soc. Trans. 2005, 33:1041-1044.
10. Bilbo S.D. Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline. Neurobiol. Learn. Mem. 2010, 94:57-64.
11. Breitner J.C., Baker L.D., Montine T.J., Meinert C.L., Lyketsos C.G., Ashe K.H., Brandt J., Craft S., Evans D.E., Green R.C., Ismail M.S., Martin B.K., Mullan M.J., Sabbagh M., Tariot P.N. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement. 2011, 7:402-411. ADAPT Research Group.
12. Cagnin A., Kassiou M., Meikle S.R., Banati R.B. Invivo evidence for microglial activation in neuro-degenerative dementia. Acta Neurol. Scand. Suppl. 2006, 185:107-114.
13. Cameron B., Tse W., Lamb R., Li X.X., Lamb B.T., Landreth G.E. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease. J.Neurosci. 2012, 32:15112-15123.
14. Carrieri P.B., Provitera V., De Rosa T., Tartaglia G., Gorga F., Perrella O. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 1998, 20:373-382.
15. Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004, 363:1139-1146.
16. Cerbai, F., Lana, D., Nosi, D., Petkova-Kirova, P., Zecchi, S., Brothers, H., Wenk, G.L., Giovannini, M.G., 2012. The neuron-astrocyte-microglia triad in normal brain aging and a model of neuroinflammation in the rat hippocampus. PlosOne 7:e45250.
17. Cheng X., Yang L., He P., Li R., Shen Y. Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. J.Alzheimers Dis. 2010, 19:621-630.
18. Colton C.A., Wilcock D.M. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 2010, 9:174-191.
19. Cribbs D.H., Berchtold N.C., Perreau V., Coleman P.D., Rogers J., Tenner A.J., Cotman C.W. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J.Neuroinflammation 2012, 9:179.
20. Dame J.B., Christensen R.D., Juul S.E. The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus. Pediatr. Res. 1999, 46:358-366.
21. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sahm L., Reim E.K., Lanctot K.L. Ameta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
22. Drye L.T., Zandi P.P. Role of APOE and age at enrollment in the Alzheimer's disease anti-inflammatory prevention trial (ADAPT). Dement. Geriatr. Cogn. Dis. Extra 2012, 2:304-311.
23. Eikelenboom P., van Exel E., Hoozemans J.J., Veerhuis R., Rosemuller A.J., van Gool W.A. Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease. Neurodegen. Dis. 2010, 7:38-41.
24. Flanary B.E., Sammons N.W., Nguyen C., Walker D., Streit W.J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 2007, 10:61-74.
25. Gerhard A., Pavese N., Hotton G., Turkheimer F., Es M., Hammers A., Eggert K., Oertel W., Banati R.B., Brooks D.J. Invivo imaging of microglial activation with [C-11](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 2006, 21:404-412.
26. Ghosh S., Wu M.D., Shaftel S.S., Kyrkanides S., La Ferla F.M., Olschowka J.A., O'Banion M.K. Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J.Neurosci. 2013, 33:5053-5064.
27. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 1998, 780:294-303.
28. Hauss-Wegrzyniak B., Galons J.P., Wenk G.L. Quantitative volumetric analysis of brain magnetic resonance imaging from rat with chronic neuroinflammation and correlation with histology. Exp. Neurol. 2000, 165:347-354.
29. Hauss-Wegrzyniak B., Lynch M.A., Vraniak P.D., Wenk G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 2002, 341:336-341.
30. Hauss-Wegrzyniak B., Vraniak P., Wenk G.L. The effects of a novel NSAID upon chronic neuroinflammation are age dependent. Neurobiol. Aging 1999, 20:305-313.
31. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 2008, 23:837-844.
32. Heneka M.T., O'Banion M.K., Terwel D., Kummer M.P. Neuroinflammatory processes in Alzheimer's disease. J.Neural Transm. 2010, 117:919-947.
33. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav. Immunol. 2009, 23:309-317.
34. Herrup K. Reimagining Alzheimer's disease: an age-based hypothesis. J.Neurosci. 2010, 30:16755-16762.
35. Hobson P., Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov. Disord. 2004, 19:1043-1049.
36. Hughes T.A., Ross H.F., Musa S., Bhattacherjee S., Nathan R.N., Mindham R.H., Spokes E.G. A10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000, 54:1596-1602.
37. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 2003, 106:518-526.
38. Kamer A.R., Craig R.G., Pirraglia E., Dassanayake A.P., Norman R.G., Boylan R.J., Nehorayoff A., Glodzik L., Brys M., de Leon M.J. TNF-α and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J.Neuroimmunol. 2009, 216:92-97.
39. Kim Y.S., Joh T.H. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders. Biomol. Ther. 2012, 20:133-143.
40. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J.Neurosci. 1995, 15:1835-1853.
41. Leoutsakos J.M., Muthen B.O., Breitner J.C., Lyketsos C.G. Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int. J. Geriat. Psychiatry 2012, 27:364-374. ADAPT Res Team.
42. Long J.M., Kalehua A.N., Muth N.J., Calhoun M.E., Jucker M., Hengemihle J.M., Ingram D.K., Mouton P.R. Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol. Aging 1998, 19:497-503.
43. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
44. Marchalant Y., Brothers H.M., Norman G.J., Karolina K., DeVries C., Wenk G.L. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiol. Dis. 2009, 34:300-307.
45. Marchalant Y., Cerbai F., Brothers H., Wenk G.L. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiol. Aging 2008, 29:1894-1901.
46. Marchalant Y., Rosi S., Wenk G.L. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience 2007, 144:1516-1522.
47. Milton I.D., Banner S.J., Ince P.G., Piggott N.H., Fray A.E., Thatcher N., Home C.H., Shaw P.J. Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study. Brain Res. Molec. Brain Res. 1997, 52:17-31.
48. Mrak R.E., Griffin W.S. Interleukin-1, neuroinflammation and Alzheimer's disease. Neurobiol. Aging 2001, 22:903-908.
49. Nam J.H., Park K.W., Park E.S., Lee Y.B., Lee H.G., Baik H.H., Kim Y.S., Maeng S., Park J., Jin B.K. Interleukin-13/-4-induced oxidative stress contributes to death of hippocampal neurons in A beta(1-42)-treated hippocampus invivo. Antiox. Redox Signal. 2012, 16:1369-1383.
50. Ownby R.L., Crocco E., Acevedo A., John V., Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 2006, 63:530-538.
51. Parajuli B., Sonobe Y., Kawanokuchi J., Doi Y., Noda M., Takeuchi H., Mizuno T., Suzumura A. GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 microglia. J.Neuroinflammation 2012, 9:268.
52. Perez F., Helmer C., Foubert-Samier A., Auriacombe S., Dartigues J.F., Tison F. Risk of dementia in an elderly population of Parkinson's disease patients: a 15-year population-based study. Alzheimers Dement. 2012, 8:463-469.
53. Perrella O., Guerriero M., Izzo E., Soscia M., Carrieri P.B. Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system. Arq. Neuropsiquiatr. 1992, 50:180-182.
54. Persson M., Brantefjord M., Hansson E., Ronnback L. Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity invitro by a mechanism dependent on TNF-alpha. Glia 2005, 51:111-120.
55. Pierson E., Simmons S.B., Castelli L., Goverman J.M. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 2012, 248:205-215.
56. Prow N.A., Irani D.N. The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J.Neurochem. 2008, 105:1276-1286.
57. Rosi S., Ramirez-Amaya V., Hauss-Wegrzyniak B., Wenk G.L. Chronic brain inflammation leads to a decline in hippocampal NMDA R1 receptors. J.Neuroinflammation 2004, 1:12-18.
58. Rosi S., Ramirez-Amaya V., Vazdarjanova A., Esperanza E., Larkin P., Fike J.R., Wenk G.L., Barnes C.A. Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain 2009, 132:2464-2486.
59. Rosi S., Ramirez-Amaya V., Vazdarjanova A., Worley P.F., Barnes C.A., Wenk G.L. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J.Neurosci. 2005, 25:723-731.
60. Rota E., Bellone G., Rocca P., Bergamasco B., Emanuelli G., Ferrero P. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol. Sci. 2006, 27:33-39.
61. Santello M., Volterra A. TNFα in synaptic function: switching gears. Trends Neurosci. 2012, 35:638-647.
62. Shi N., Kawano Y., Tateishi T., Kikuchi H., Osoegawa M., Ohyagi Y., Kira J. Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate. J.Neuroimmunol. 2007, 182:232-235.
63. Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 2012, 87:10-20.
64. Streit W.J., Braak H., Xue Q.S., Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 2009, 118:475-485.
65. Streit W.J., Xue Q.S. Life and death of microglia. J.Neuroimmune Pharmacol. 2009, 4:371-379.
66. Sudduth T.L., Schmitt F.A., Nelson P.T., Wilcock D.M. Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol. Aging 2013, 34:1051-1059.
67. Tarkowski E., Wallin A., Regland B., Blennow K., Tarkowski A. Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol. Scand. 2001, 103:166-174.
68. Wenk G.L., Hauss-Wegrzyniak B. Animal models of chronic neuroinflammation as a model of Alzheimer's Disease. Inflammatory Events in Neurodegeneration 2001, 83-87. Prominent Press, Scottsdale, AZ. S. Bondy, A. Campbell (Eds.).
69. Wenk G.L., Hauss-Wegrzyniak B., Willard L.B. Pathological and biochemical studies of chronic neuroinflammation may lead to therapies for Alzheimer's disease. Research and Perspectives in Neurosciences: Neuro-Immune Neurodegenerative and Psychiatric Disorders and Neural Injury 2000, 73-77. Springer-Verlag, Heidelberg. P. Patterson, C. Kordon, Y. Christen (Eds.).